Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-20-019906

Chief Business Officer acquired 10,529 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Caffo Nathan Chief Business Officer 2020-07-21 Conversion +10,529 11,254 I
Derivatives
Caffo Nathan Chief Business Officer 2020-07-21 Conversion · Series B Convertible Preferred Stock −10,529 0 I
Loading xslF345X03/doc4.xml…